BillionToOne, Inc.(BLLN), a molecular diagnostics company, on Monday reaffirmed its outlook for fiscal 2025 and initiated guidance for 2026.
For fiscal 2025, the company still expects revenue of $293 million to $299 million with positive net operating income. For fiscal 2024, BillionToOne had registered revenue of $153 million.
For fiscal 2026, BillionToOne anticipates revenue of $415 million to $430 million, with positive net operating earnings.
On average, 8 analysts polled forecast the firm to generate revenue of $296.24 million for 2025 and $393.61 million for 2026. Analysts' estimates typically exclude special items.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.